Amneal Pharmaceuticals
AMRX
AMRX
129 hedge funds and large institutions have $488M invested in Amneal Pharmaceuticals in 2019 Q4 according to their latest regulatory filings, with 27 funds opening new positions, 50 increasing their positions, 32 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
9.07% less ownership
Funds ownership: 84.51% → 75.43% (-9.1%)
91% less call options, than puts
Call options by funds: $75K | Put options by funds: $850K
Holders
129
Holding in Top 10
1
Calls
$75K
Puts
$850K
Top Buyers
| 1 | +$9M | |
| 2 | +$4.68M | |
| 3 | +$3.79M | |
| 4 |
MSL
Mackay Shields LLC
New York
|
+$3.78M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$3.45M |
Top Sellers
| 1 | -$32.7M | |
| 2 | -$8.28M | |
| 3 | -$2.93M | |
| 4 |
Norges Bank
Oslo,
Norway
|
-$1.79M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
-$1.76M |